Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overactive Bladder (OAB)”

243 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 243 results

Post-approval studies (Phase 4)Study completedNCT02294396
What this trial is testing

Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

Who this might be right for
Overactive Bladder (OAB)
Astellas Pharma Inc 649
Not applicableStudy completedNCT05368246
What this trial is testing

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

Who this might be right for
Urinary IncontinenceFecal IncontinenceUrge Incontinence+5 more
InnoCon Medical 80
Not applicableWithdrawnNCT03019094
What this trial is testing

Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1

Who this might be right for
Overactive Bladder
BlueWind Medical
Post-approval studies (Phase 4)Looking for participantsNCT06953271
What this trial is testing

Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection

Who this might be right for
Overactive Bladder (OAB)Urinary Tract Infection (Diagnosis)
Women and Infants Hospital of Rhode Island 164
Post-approval studies (Phase 4)Study completedNCT00366002
What this trial is testing

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)
Novartis 500
Not applicableStudy completedNCT02299544
What this trial is testing

BlueWind Medical System for the Treatment of Patients With OAB

Who this might be right for
Over Active Bladder
BlueWind Medical 36
Not applicableLooking for participantsNCT07081412
What this trial is testing

Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation

Who this might be right for
Overactive Bladder SyndromeOveractive Bladder (OAB)Transcutaneous Posterior Tibial Nerve Stimulation (TTNS)
Ege University 50
Post-approval studies (Phase 4)Study completedNCT01833663
What this trial is testing

Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

Who this might be right for
Overactive BladderPostmenopausal DisorderUrination Disorders
Peking Union Medical College Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00742833
What this trial is testing

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)
Kissei Pharmaceutical Co., Ltd. 400
Not applicableLooking for participantsNCT06789406
What this trial is testing

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

Who this might be right for
Urinary Urge Incontinence (UUI)Urinary Frequency (UF)Overactive Bladder (OAB)
Axonics, Inc. 55
Not applicableStudy completedNCT02620410
What this trial is testing

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)

Who this might be right for
Overactive Bladder
Axonics, Inc. 51
Testing effectiveness (Phase 2)Ended earlyNCT00439192
What this trial is testing

ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

Who this might be right for
Overactive BladderUrinary Incontinence
elbion AG 275
Not applicableLooking for participantsNCT07377929
What this trial is testing

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

Who this might be right for
Benign Prostatic Hypertrophy (BPH)Lower Urinary Track Symptoms
Benaroya Research Institute 20
Not applicableLooking for participantsNCT06659536
What this trial is testing

Cefar URO - Symptomatic Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder (OAB)Refractory Overactive BladderUrinary Urgency and Frequency
DJO UK Ltd 53
Post-approval studies (Phase 4)WithdrawnNCT00773552
What this trial is testing

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

Who this might be right for
Urinary UrgeUrge IncontinenceOveractive Bladder
Stamford Hospital
Not applicableLooking for participantsNCT06783374
What this trial is testing

Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence

Who this might be right for
Urge Urinary IncontinenceOveractive Bladder (OAB)
Fundación Universidad Católica de Valencia San Vicente Mártir 63
Not applicableStudy completedNCT03556891
What this trial is testing

Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence

Who this might be right for
Overactive BladderUrge IncontinenceIncontinence, Urinary+1 more
Valencia Technologies Corporation 133
Large-scale testing (Phase 3)Study completedNCT03902080
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 1,105
Post-approval studies (Phase 4)Study completedNCT00127270
What this trial is testing

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Who this might be right for
Urinary Incontinence
Novartis 395
Post-approval studies (Phase 4)Study completedNCT02656173
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Who this might be right for
Overactive Bladder
Astellas Pharma Inc 568
Next Page